Tempest Therapeutics Inc (TPST)

Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Interest Income/Expense	2.39% 0.368	0.377	0.373	0.355	0.344
Operating Income/Loss	6.12% -7.974	-7.514	-6.592	-7.47	-7.581
Nonoperating Income/Loss	169.23% 0.07	0.026	-0.194	-0.111	-0.055
Income/Loss From Continuing Operations Before Tax	5.56% -7.904	-7.488	-6.786	-7.581	-7.636
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	5.56% -7.904	-7.488	-6.786	-7.581	-7.636
Net Income/Loss	5.56% -7.904	-7.488	-6.786	-7.581	-7.636
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,538% 22.23	1.3572	14.12	14.10	13.76
Diluted Average Shares	1,538% 22.23	1.3572	14.12	14.10	13.76
Basic Earnings Per Share	5.88% -0.36	-0.34	-0.48	-0.54	-0.55
Diluted Earnings Per Share	5.88% -0.36	-0.34	-0.48	-0.54	-0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-